Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The gut-liver-axis: endotoxemia, inflammation, insulin resistance and NASH.

Literature DB >> 18468548

The gut-liver-axis: endotoxemia, inflammation, insulin resistance and NASH.

Jürgen Siebler¹, Peter R Galle, Matthias M Weber.

Abstract

Entities: Disease Gene

Year: 2008 PMID： 18468548 DOI： 10.1016/j.jhep.2008.03.007

Source DB: PubMed Journal: J Hepatol ISSN： 0168-8278 Impact factor: 25.083

Keyword Cloud
Cited

× No keyword cloud information.

21 in total

1. Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia.

Authors: Melissa J Puppa; James P White; Shuichi Sato; Mark Cairns; John W Baynes; James A Carson
Journal: Biochim Biophys Acta Date: 2011-09-02

2. Association of gut microbial communities with plasma lipopolysaccharide-binding protein (LBP) in premenopausal women.

Authors: Jessica S Citronberg; Keith R Curtis; Emily White; Polly A Newcomb; Katherine Newton; Charlotte Atkinson; Xiaoling Song; Johanna W Lampe; Meredith Aj Hullar
Journal: ISME J Date: 2018-02-12 Impact factor: 10.302

3. Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation.

Authors: Diptadip Dattaroy; Ratanesh Kumar Seth; Suvarthi Das; Firas Alhasson; Varun Chandrashekaran; Gregory Michelotti; Daping Fan; Mitzi Nagarkatti; Prakash Nagarkatti; Anna Mae Diehl; Saurabh Chatterjee
Journal: Am J Physiol Gastrointest Liver Physiol Date: 2015-12-30 Impact factor: 4.052

4. Molecular MR Imaging of Myeloperoxidase Distinguishes Steatosis from Steatohepatitis in Nonalcoholic Fatty Liver Disease.

Authors: Benjamin Pulli; Gregory Wojtkiewicz; Yoshiko Iwamoto; Muhammad Ali; Matthias W Zeller; Lionel Bure; Cuihua Wang; Yuri Choi; Ricard Masia; Alex R Guimaraes; Kathleen E Corey; John W Chen
Journal: Radiology Date: 2017-03-30 Impact factor: 11.105

The gut-liver-axis: endotoxemia, inflammation, insulin resistance and NASH.

1. Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia.

2. Association of gut microbial communities with plasma lipopolysaccharide-binding protein (LBP) in premenopausal women.

3. Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation.

4. Molecular MR Imaging of Myeloperoxidase Distinguishes Steatosis from Steatohepatitis in Nonalcoholic Fatty Liver Disease.

Review 5. Role of resistant starch in improving gut health, adiposity, and insulin resistance.

Review 6. Breath volatile organic compounds for the gut-fatty liver axis: promise, peril, and path forward.

Review 7. The gut microbiota and obesity: from correlation to causality.

8. Zinc transporter Slc39a14 regulates inflammatory signaling associated with hypertrophic adiposity.

9. A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese.

10. Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis.